Status:
COMPLETED
To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence
Lead Sponsor:
Eli Lilly and Company
Collaborating Sponsors:
Boehringer Ingelheim
Conditions:
Stress Urinary Incontinence
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
The patients are being followed in this study to determine the safety of taking the medication Duloxetine for a long period of time. The patients participating in this study suffer from Stress Urinary...
Eligibility Criteria
Inclusion
- Successfully completed the protocol for Study F1J-MC-SBAV.
- \-
Exclusion
- Treatment with a drug, not including study medication, that has not received regulatory approval at the time of study entry.
- Use of excluded medications within 14 days prior to study entry or at any time during the study.
- \-
Key Trial Info
Start Date :
February 1 2001
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00190645
Start Date
February 1 2001
End Date
May 1 2006
Last Update
January 26 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician
Denver, Colorado, United States, 80220
2
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559,1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician
Oakville, Ontario, Canada, L6H3P1